Search results
Results From The WOW.Com Content Network
Ketamine can be effective for people with treatment-resistant depression. ... eight participants reported severe side effects, including severe depression, severe headache, and chest pain ...
Duloxetine, sold under the brand name Cymbalta among others, [1] is a medication used to treat major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, fibromyalgia, neuropathic pain and central sensitization. [7] [8] It is taken by mouth. [7]
Mayo Clinic is a nonprofit hospital system with campuses in Rochester, Minnesota; Scottsdale and Phoenix, Arizona; and Jacksonville, Florida. [22] [23] Mayo Clinic employs 76,000 people, including more than 7,300 physicians and clinical residents and over 66,000 allied health staff, as of 2022. [5] In addition, Mayo Clinic partially owns and ...
Methadone, sold under the brand names Dolophine and Methadose among others, is a synthetic opioid agonist used for chronic pain and also for opioid use disorder. [7] It is used to treat chronic pain, and it is also used to treat addiction to heroin or other opioids. [10] [11] Prescribed for daily use, the medicine relieves cravings and removes ...
Like other SSRIs, sertraline can cause a range of possible side effects that typically occur during the first few weeks of treatment, including: Nausea. Fatigue and tiredness. Intimacy problems ...
In an alert Wednesday to health care providers, the CDC said that a dozen people in eight states have gotten sick after eating the brand’s “microdosing” mushroom edibles. All but two needed ...
Alprazolam, sold under the brand name Xanax and others, is a fast-acting, potent tranquilizer of moderate duration within the triazolobenzodiazepine group of chemicals called benzodiazepines. [15] Alprazolam is most commonly prescribed in the management of anxiety disorders, especially panic disorder and generalized anxiety disorder (GAD). [9]
While an estimated 9% of the US population will have an eating disorder at some point, studies suggest that somewhere between 0.5% and 5% of the population has ARFID, according to the National ...